Article info

Download PDFPDF

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

Authors

  1. i (713) 794-5073 ywang59{at}mdanderson.org
View Full Text

Citation

Abu-Sbeih H, Ali FS, Alsaadi D, et al
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

Publication history

  • Received October 3, 2018
  • Accepted November 20, 2018
  • First published December 5, 2018.
Online issue publication 
December 05, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.